Marshall Wace North America’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $670K | Buy |
+15,362
| New | +$670K | ﹤0.01% | 1004 |
|
|
2021
Q2 | – | Sell |
-1,245
| Closed | -$60K | – | 1911 |
|
|
2021
Q1 | $60K | Sell |
1,245
-12,086
| -91% | -$582K | ﹤0.01% | 1413 |
|
|
2020
Q4 | $1.31M | Sell |
13,331
-21,221
| -61% | -$2.09M | 0.01% | 873 |
|
|
2020
Q3 | $2.38M | Sell |
34,552
-33,634
| -49% | -$2.32M | 0.02% | 539 |
|
|
2020
Q2 | $7.2M | Buy |
68,186
+38,379
| +129% | +$4.05M | 0.05% | 312 |
|
|
2020
Q1 | $2.65M | Buy |
+29,807
| New | +$2.65M | 0.02% | 433 |
|
|
2018
Q2 | – | Sell |
-657
| Closed | -$83K | – | 1815 |
|
|
2018
Q1 | $83K | Buy |
+657
| New | +$83K | ﹤0.01% | 1373 |
|
|
2017
Q4 | – | Sell |
-579
| Closed | -$185K | – | 1690 |
|
|
2017
Q3 | $185K | Buy |
+579
| New | +$185K | ﹤0.01% | 1183 |
|